Antemortem measurements of neurotransmission: possible implications for pharmacotherapy of Alzheimer's disease and depression.
Open Access
- 1 January 1993
- journal article
- research article
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 56 (1) , 80-84
- https://doi.org/10.1136/jnnp.56.1.80
Abstract
Aspartic acid, 5-hydroxyindoleacetic acid, glutamic acid, homovanillic acid and 3-methoxy-4-hydroxyphenylethylene glycol was determined in samples of ventricular fluid from 82 subjects. Laminar distribution of the total number (Bmax value) of serotonin 1A receptors was determined on seven neurosurgical samples of neocortex. Apart from an association in a small subgroup of subjects between homovanillate concentration and corticosteroid medication, no complicating influences of treatment preceding operation were found. The content of the serotonin metabolite alone was significantly reduced in intractable depressive illness (bipolar and major depressive disorders) compared with neurological conditions subdivided into Alzheimer's disease, other dementias and other conditions. There was no other significant difference between these groups for the compounds measured. The total number of serotonin 1A receptors was highest in the superficial layers, being considerably higher than in the rat, irrespective of cortical layer. This part of the study indicated that these receptors are important for regulating activity of human corticocortical glutamatergic neurons. The results are discussed in relation to treating depression with serotonergic agents and targeting corticocortical glutamatergic neurons as well as acetylcholine in Alzheimer's disease.Keywords
This publication has 28 references indexed in Scilit:
- Animal and drug modelling for Alzheimer synaptic pathologyProgress in Neurobiology, 1992
- Effect of Psychotropic Drugs on Excitatory Amino Acids in Patients Undergoing Psychosurgery for DepressionThe British Journal of Psychiatry, 1992
- ReplyTrends in Neurosciences, 1991
- d-Cycloserine, a putative cognitive enhancer, facilitates activation of the N-methyl-d-aspartate receptor-ionophore complex in Alzheimer brainBrain Research, 1991
- Characterization of a novel and potent 5-hydroxytryptamine1A receptor antagonistPharmacology Biochemistry and Behavior, 1991
- Amyloid deposition as the central event in the aetiology of Alzheimer's diseaseTrends in Pharmacological Sciences, 1991
- High affinity serotonin binding sites in human brain: a comparison of cerebral cortex and basal gangliaJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1989
- Possible neurotransmitter basis of behavioral changes in alzheimer's diseaseAnnals of Neurology, 1988
- Monoamine metabolite concentrations in lumbar cerebrospinal fluid of patients with histologically verified Alzheimer's dementia.Journal of Neurology, Neurosurgery & Psychiatry, 1984
- Contemporary Indications for PsychosurgeryThe British Journal of Psychiatry, 1981